Vascular Closure Devices

FDA Clears Cardiva Medical’s Vascade Vascular Closure System

Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Vascade Vascular Closure System (VCS). Clinical data from a prospective, multi-center, randomized 420 patient trial demons...

AccessClosure Launches MynxGrip Vascular Closure Device

February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the MynxGrip VCD offers an active, extravascular and p...

Sealing the Access Site
For decades, cath lab clinicians essentially had only one option for achieving hemostasis management following a procedure – compression. That changed in the 1990s with the introduction of vascular closure devices and hemostatic pads, which were desi...
Arteriotomy Devices Reasonable, But More Research Needed

October 6, 2010 – A new statement from the American Heart Association says arteriotomy closure devices are reasonable to use, but their benefits should be weighed against the risk of complications.

CardioLogical Solutions is Accessorizing TAVR to Make...
CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory...
Cardiva Medical FDA Pre Market Approval Vascade VCS
FDA Clears Cardiva Medical’s Vascade Vascular Closure System
Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Vascade Vascular Closure System (...
First-In-Human Clinical Trial Completed for FastSeal...
Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the first-in-human (FIH) clinical trial for its 6/7 French...
Vascular Solutions Launches R-Band Radial Hemostasis Device
November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United States. Vascular Solutions is the exclusive...
Cardiva Medical FDA Pre Market Approval Vascade VCS
Vascade VCS Provides Temporary Hemostasis During Vascular Closure
Cardiva Medical's Vascade Vascular Closure System (VCS), an extravascular closure device, utilizes a unique delivery system based on a
Vascular Solutions Launches R-Band Radial Hemostasis Device
Vascular Solutions is the exclusive distributor of the R-Band radial hemostasis compression device in the United States under an agreement...
AccessClosure Launches MynxGrip Vascular Closure Device
February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip...
Vascular Closure Device has More Consistent Sealant Delivery
The Mynx Cadence Vascular Closure Device (VCD), from AccessClosure, offers physicians smoother device deployment while maintaining all the...
View All »

Articles

An extracted bovine artery with an arteriotomy sealed by a MynxGrip closure dev
Bioresorbable Vascular Closure Devices Speed Ambulation
Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ambulation, reduce nursing time...
The implementation of dedicated access site surveillance and educational program
Targeted Surveillance, Training Reduces Access Site...
The implementation of dedicated access site surveillance and educational programs, in tandem with pre-existent strategies to reduce access site complications,...
TAVR, EVAR Vascular Closure Device May Eliminate Need for...
Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a...
Advances in Vascular Closure Technology
Manual compression remains the gold standard of care in sealing interventional access site wounds, but there is a trend toward newer technologies that promise...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
10 weeks 4 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
14 weeks 6 days ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
18 weeks 4 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available